Endometrial Immune Profiling: A Method to Design Personalized Care in Assisted Reproductive Medicine
- PMID: 32582163
- PMCID: PMC7287127
- DOI: 10.3389/fimmu.2020.01032
Endometrial Immune Profiling: A Method to Design Personalized Care in Assisted Reproductive Medicine
Abstract
Objective: To assess the efficiency of the endometrial immune profiling as a method to design personalized care to enhance the pregnancy rate in a large heterogeneous infertile population. We hypothesized that some reproductive failures could be induced by a uterine immune dysregulation which could be identified and corrected with a targeted plan. Design: Prospective cohort study. Setting: Multicentric study. Intervention(s) and Main outcome measure(s): One thousand and seven hundred thirty-eight infertile patients had an immune profiling on a timed endometrial biopsy between 2012 and 2018. This test documented the absence or the presence of an endometrial immune dysregulation and identified its type. In case of dysregulation, a targeted personalized plan was suggested to the treating clinician aiming to supply the anomaly. One year after the test, the clinician was contacted to provide the outcome of the subsequent embryo transfer with the applied suggested plan. Result(s): After testing, 16.5% of the patients showed no endometrial immune dysregulation, 28% had a local immune under-activation, 45% had a local immune over-activation, and 10.5% had a mixed endometrial immune profile. In patients with a history of repeated implantation failures (RIF) or recurrent miscarriages (RM), the pregnancy rate was significantly higher if an endometrial dysregulation was found and the personalized plan applied, compared to the patients with an apparent balanced immune profile (respectively 37.7 and 56% vs. 26.9 and 24%, p < 0.001). In contrast, in good prognosis IVF (in vitro fertilization) subgroup and patients using donor eggs, this difference was not significant between dysregulated and balanced subgroups, but higher pregnancy rates were observed in absence of dysregulation. For patients with immune over-activation, pregnancy rates were significantly higher for patients who had a test of sensitivity, regarding the type of immunotherapy introduced, when compared to the ones who did not (51 vs. 39.9%, p = 0.012). Conclusion(s): Local endometrial immunity appears to be a new and important parameter able to influence the prognosis of pregnancy. Targeted medical care in case of local immune dysregulation resulted in significantly higher pregnancy rates in RIF and RM patients.
Keywords: IVF; embryo implantation; endometrium; immunology; pregnancy.
Copyright © 2020 Lédée, Petitbarat, Prat-Ellenberg, Dray, Cassuto, Chevrier, Kazhalawi, Vezmar and Chaouat.
Similar articles
-
The Endometrial Immune Profiling May Positively Affect the Management of Recurrent Pregnancy Loss.Front Immunol. 2021 Mar 24;12:656701. doi: 10.3389/fimmu.2021.656701. eCollection 2021. Front Immunol. 2021. PMID: 33841443 Free PMC article.
-
The uterine immune profile: A method for individualizing the management of women who have failed to implant an embryo after IVF/ICSI.J Reprod Immunol. 2020 Nov;142:103207. doi: 10.1016/j.jri.2020.103207. Epub 2020 Sep 14. J Reprod Immunol. 2020. PMID: 32971456 Review.
-
Uterine immune profiling for increasing live birth rate: A one-to-one matched cohort study.J Reprod Immunol. 2017 Feb;119:23-30. doi: 10.1016/j.jri.2016.11.007. Epub 2016 Nov 24. J Reprod Immunol. 2017. PMID: 27915039
-
Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis.Hum Reprod Update. 2014 May-Jun;20(3):429-38. doi: 10.1093/humupd/dmt056. Epub 2013 Nov 27. Hum Reprod Update. 2014. PMID: 24285824 Review.
-
The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure.Fertil Steril. 2013 Sep;100(3):818-24. doi: 10.1016/j.fertnstert.2013.05.004. Epub 2013 Jun 4. Fertil Steril. 2013. PMID: 23756099 Clinical Trial.
Cited by
-
Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes.Sci Rep. 2024 Feb 16;14(1):3876. doi: 10.1038/s41598-024-54423-z. Sci Rep. 2024. PMID: 38365988 Free PMC article.
-
Endometrial immune profiling as a new tool for preconceptional assessment in patients with systemic autoimmune diseases.Front Immunol. 2024 Jan 5;14:1334231. doi: 10.3389/fimmu.2023.1334231. eCollection 2023. Front Immunol. 2024. PMID: 38250081 Free PMC article. No abstract available.
-
Endometrial biopsy performed before the first in vitro fertilization does not impact the early pregnancy rate.Sci Rep. 2024 Jan 11;14(1):1153. doi: 10.1038/s41598-023-50715-y. Sci Rep. 2024. PMID: 38212636 Free PMC article. Clinical Trial.
-
The Next Frontier in ART: Harnessing the Uterine Immune Profile for Improved Performance.Int J Mol Sci. 2023 Jul 11;24(14):11322. doi: 10.3390/ijms241411322. Int J Mol Sci. 2023. PMID: 37511080 Free PMC article. Review.
-
ESHRE good practice recommendations on recurrent implantation failure.Hum Reprod Open. 2023 Jun 15;2023(3):hoad023. doi: 10.1093/hropen/hoad023. eCollection 2023. Hum Reprod Open. 2023. PMID: 37332387 Free PMC article.
References
-
- Rutstein SO, Shah IH. Infecundity, Infertility, Childlessness in Developing Countries. DHS Comparative Reports No. 9. Geneva: World Health Organization; (2004).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical